Pharmacogenetic information for patients on drug labels

References

• FruehFWAmurSMummaneniPPharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug usePharmacotherapy200828899299818657016
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationTable of Pharmacogenomic Biomarkers in Drug Labels Available from: http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htmAccessed May 13, 2014
   Google Scholar
• CharlandSLAgatepBCHerreraVProviding patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trialPharmacogenomics J201414327228023979174
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationRequirements on content and format of labeling for human prescription drug and biological products. January 24, 71 FR 39222006Code of Federal Regulations §§ 201.56 and 201.57 Available from: http://www.fda.gov/ohrms/dockets/98fr/06-545.pdfAccessed July 22, 2014
   Google Scholar
• US Food and Drug AdministrationLabeling for human prescription drug and biological products – implementing the PLR content and format requirements22013 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075082.pdfAccessed May 13, 2014
   Google Scholar
• US Food and Drug AdministrationGuidance for industry: patient counseling information section of labeling for human prescription drug and biological products – content and format92013 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368602.pdfAccessed May 13, 2014
   Google Scholar
• US Food and Drug AdministrationPatient package inserts for oral contraceptives Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=310.50121CFR310.501Accessed July 22, 2014
   Google Scholar
• US Food and Drug AdministrationPatient package inserts for estrogens. 21CFR310.515 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=310.515Accessed July 22, 2014
   Google Scholar
• US Food and Drug AdministrationMedication guides for prescription drug products. 21CFR208 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=208.20Accessed July 22, 2014
   Google Scholar
• StewartMBrownJBDonnerAThe impact of patient-centered care on outcomesJ Fam Pract200049979680411032203
   PubMed Web of Science ®Google Scholar
• WeinerSJSchwartzASharmaGPatient-centered decision making and health care outcomes: an observational studyAnn Intern Med2013158857357923588745
   PubMed Web of Science ®Google Scholar
• McMillanSSKendallESavAPatient-centered approaches to health care: a systematic review of randomized controlled trialsMed Care Res Rev201370656759623894060
   PubMed Web of Science ®Google Scholar
• ConradoDJRogersHLZinehIPacanowskiMAConsistency of drug-drug and gene-drug interaction information in US FDA-approved drug labelsPharmacogenomics201314221522323327581
   PubMed Web of Science ®Google Scholar
• SeminerioMJRatainMJAre drug labels static or dynamic?Clin Pharmacol Ther201394330230423963217
   PubMed Web of Science ®Google Scholar
• DrozdaKMullerDJBishopJRPharmacogenomic testing for neuropsy-chiatric drugs: current status of drug labeling, guidelines for using genetic information, and test optionsPharmacotherapy201434216618424523097
   PubMed Web of Science ®Google Scholar
• OtsuboYAsahinaYNoguchiASatoYAndoYUyamaYSimilarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labelsDrug Metab Pharmacokinet201227114214922201121
   PubMed Web of Science ®Google Scholar
• ShimazawaRIkedaMDifferences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and JapanJ Clin Pharm Ther201338646847523895776
   PubMed Web of Science ®Google Scholar
• Depakene (valproic acid): prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018081s056lbl.pdfAccessed July 22, 2014
   Google Scholar
• Ziagen (abacavir sulfate) medication guide2012 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm224556.pdfAccessed July 22, 2014
   Google Scholar
• Revlimid (lenalidomide) medication guide2013 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111335.pdfAccessed July 22, 2014
   Google Scholar
• Gilotrif (afatinib) prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201292s002lbl.pdfAccessed July 22, 2014
   Google Scholar
• Xeloda (capecitabine) prescribing information2010 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020896s026lbl.pdfAccessed July 22, 2014
   Google Scholar
• Carac (fluorouracil) prescription information2003 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20985slr004_carac_lbl.pdfAccessed July 22, 2014
   Google Scholar
• Aczone (dapsone) prescribing information2009 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021794s006lbl.pdfAccessed July 22, 2014
   Google Scholar
• Codeine sulfate prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022402s006lbl.pdfAccessed July 22, 2014
   Google Scholar
• Krystexxa (pegloticase) medication guide2012 Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM227568.pdfAccessed July 22, 2014
   Google Scholar
• Zelboraf (vemurafenib) prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202429s002s003lbl.pdfAccessed July 22, 2014
   Google Scholar
• Allen LaPointeNMPappasPDeverkaPAnstromKJPatient receipt and understanding of written information provided with isotretinoin and estrogen prescriptionsJ Gen Intern Med20072219810117351847
   PubMed Web of Science ®Google Scholar
• WolfMSDavisTCShrankWHNeubergerMParkerRMA critical review of FDA-approved medication guidesPatient Educ Counsel2006623316322
   PubMed Web of Science ®Google Scholar
• WolfMSKingJWilsonEAUsability of FDA-approved medication guidesJ Gen Intern Med201227121714172022566170
   PubMed Web of Science ®Google Scholar
• ShiffmanSGerlachKKSembowerMARohayJMConsumer understanding of prescription drug information: an illustration using an antidepressant medicationAnn Pharmacother201145445245821427296
   PubMed Web of Science ®Google Scholar
• RoseDRussoJWykesTTaking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent processBMC Med Ethics2013143424025622
   PubMed Web of Science ®Google Scholar
• StormABenfeldtEAndersenSEAndersenJBasic drug information given by physicians is deficient, and patients’ knowledge lowJ Dermatolog Treat200920419019319040185
   PubMed Web of Science ®Google Scholar
• NairKDolovichLCasselsAWhat patients want to know about their medicationsCan Fam Physician20024810411011852597
   PubMed Web of Science ®Google Scholar
• DickinsonDRaynorDKWhat information do patients need about medicines? Ask the patients – they may want to know more than you thinkBMJ2003327741986114551106
   PubMedGoogle Scholar
• McCormackJPDolovichLLevineMProviding evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?Health Expect20036428128915040790
   PubMedGoogle Scholar
• NathanJPZerilliTCiceroLARosenbergJMPatients’ use and perception of medication information leafletsAnn Pharmacother200741577778217405820
   PubMed Web of Science ®Google Scholar
• SchmittMRMillerMJHarrisonDLCommunicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awarenessPatient Educ Counsel2011833391397
   Web of Science ®Google Scholar
• RaynorDKSavageIKnappPHenleyJWe are the experts: people with asthma talk about their medicine information needsPatient Educ Counsel2004532167174
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationInformation for Consumers (drugs)2014 Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/default.htmAccessed May 13, 2014
   Google Scholar
• US Food and Drug AdministrationDevelopment and distribution of patient medication information for prescription drugs; public hearingUS Department of Health and Human Services Federal Register2010751665276552768 Available from: http://www.fda.gov/drugs/newsevents/ucm219716.htmAccessed July 22, 2014
   Google Scholar
• BerryDCRaynorDKKnappPBerselliniEPatients’ understanding of risk associated with medication use – impact of European Commission guidelines and other risk scalesDrug Saf200326111112495359
   PubMed Web of Science ®Google Scholar